Michael Kelley

Michael Kelley is a seasoned professional in the field of medical writing and regulatory documentation, currently serving as the Director of Infectious Disease Medical Writing at Moderna since May 2024. Prior to this, Michael held the position of Director of Regulatory Medical Writing at Organon, and served in various leadership roles at Gilead Sciences, including Director and Associate Director of Regulatory Documentation and Submissions. Michael's experience also includes a tenure as Senior Manager of Medical Writing at inSeption Group and over 25 years at Amgen Inc. where positions included Director of Global Regulatory Writing and Regulatory Writing Senior Manager. Michael holds a PhD and a BS from Rutgers University, with degrees earned between 1981 and 1989.